SCHEMBL28343441

SCHEMBL28343441

CN(C)CC(OC(C)(C)C)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18819240 0.74
SCHEMBL17231760 0.73 MAPK1 (0.41)
SCHEMBL22063620 0.72 TSHR (0.30)
SCHEMBL22924156 0.72 TSHR (0.30)
SCHEMBL11358455 0.70
SCHEMBL9637535 0.69
SCHEMBL11102223 0.69
SCHEMBL23179730 0.68
SCHEMBL23879558 0.67 PRKCA (0.31)
SCHEMBL3731819 0.67 THRB (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115135656-A Furanoinindazole derivatives 拜耳公司 2022-09-30 CN disclosed
CN-106795199-B 4' -substituted nucleoside derivatives as HIV reverse transcriptase inhibitors 默沙东公司 2020-01-10 CN disclosed